Fidelity Investments’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-262,473
| Closed | -$55.3K | – | 5614 |
|
|
2023
Q2 | $55.3K | Sell |
262,473
-545
| -0.2% | -$95 | ﹤0.01% | 3390 |
|
|
2023
Q1 | $42.1K | Buy |
263,018
+880
| +0.3% | +$391 | ﹤0.01% | 3522 |
|
|
2022
Q4 | $145K | Sell |
262,138
-388
| -0.1% | -$330 | ﹤0.01% | 3092 |
|
|
2022
Q3 | $312K | Sell |
262,526
-1,352
| -0.5% | -$1.46K | ﹤0.01% | 2922 |
|
|
2022
Q2 | $167K | Buy |
263,878
+411
| +0.2% | +$316 | ﹤0.01% | 3169 |
|
|
2022
Q1 | $300K | Buy |
+263,467
| New | +$315K | ﹤0.01% | 3141 |
|
|
2019
Q4 | – | Sell |
-750
| Closed | -$1K | – | 4384 |
|
|
2019
Q3 | $1K | Hold |
750
| – | – | ﹤0.01% | 3701 |
|
|
2019
Q2 | $1K | Hold |
750
| – | – | ﹤0.01% | 3672 |
|
|
2019
Q1 | $1K | Hold |
750
| – | – | ﹤0.01% | 3535 |
|
|
2018
Q4 | $1K | Buy |
+750
| New | +$1.35K | ﹤0.01% | 3447 |
|
|
2018
Q2 | – | Sell |
-3,588,249
| Closed | -$7.54M | – | 2735 |
|
|
2018
Q1 | $7.54M | Hold |
3,588,249
| – | – | ﹤0.01% | 2035 |
|
|
2017
Q4 | $7.28M | Buy |
+3,588,249
| New | +$7.44M | ﹤0.01% | 2043 |
|
|
2017
Q3 | – | Sell |
-222,373
| Closed | -$349K | – | 2657 |
|
|
2017
Q2 | $349K | Buy |
+222,373
| New | +$429K | ﹤0.01% | 2538 |
|
|
2017
Q1 | – | Sell |
-1,188,976
| Closed | -$1.6M | – | 2719 |
|
|
2016
Q4 | $1.6M | Buy |
1,188,976
+42,476
| +4% | +$55.5K | ﹤0.01% | 2408 |
|
|
2016
Q3 | $1.79M | Buy |
1,146,500
+60,000
| +6% | +$92.2K | ﹤0.01% | 2385 |
|
|
2016
Q2 | $1.45M | Sell |
1,086,500
-1,279,325
| -54% | -$5.98M | ﹤0.01% | 2431 |
|
|
2016
Q1 | $12.5M | Buy |
2,365,825
+12,658
| +0.5% | +$77.5K | ﹤0.01% | 1866 |
|
|
2015
Q4 | $18.5M | Buy |
2,353,167
+256,800
| +12% | +$2.21M | ﹤0.01% | 1718 |
|
|
2015
Q3 | $17.7M | Sell |
2,096,367
-67,581
| -3% | -$623K | ﹤0.01% | 1698 |
|
|
2015
Q2 | $23.7M | Sell |
2,163,948
-243,994
| -10% | -$3.13M | ﹤0.01% | 1662 |
|
|
2015
Q1 | $33.7M | Sell |
2,407,942
-843,300
| -26% | -$12.9M | ﹤0.01% | 1517 |
|
|
2014
Q4 | $54.9M | Sell |
3,251,242
-122,700
| -4% | -$1.79M | 0.01% | 1283 |
|
|
2014
Q3 | $45.3M | Sell |
3,373,942
-1,616,245
| -32% | -$19.2M | 0.01% | 1345 |
|
|
2014
Q2 | $63.6M | Buy |
4,990,187
+471,575
| +10% | +$4.91M | 0.01% | 1240 |
|
|
2014
Q1 | $53.7M | Buy |
4,518,612
+570,746
| +14% | +$7.66M | 0.01% | 1286 |
|
|
2013
Q4 | $54.5M | Sell |
3,947,866
-2,721,603
| -41% | -$38.4M | 0.01% | 1272 |
|
|
2013
Q3 | $116M | Sell |
6,669,469
-504,572
| -7% | -$9.66M | 0.02% | 876 |
|
|
2013
Q2 | $117M | Buy |
+7,174,041
| New | +$222M | 0.02% | 840 |
|
Other funds holding INFI
Fidelity Investments's INFI Position: Q3 2023 in Review
Fidelity Investments sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 262,473 shares — an estimated $55.3K sold.
Fidelity Investments first reported a position in INFI in Q2 2013 and held it in 28 quarters. The position peaked at $117M in Q2 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Fidelity Investments reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Fidelity Investments sold 262,473 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $55.3K.
- Fidelity Investments first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
- Fidelity Investments's Infinity Pharmaceuticals, Inc. position peaked at $117M in Q2 2013.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.